/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Tom Ward

Tom Ward

Staff Writer

Latest Stories

Futurism
6.6.17, 12:38 PM EDT on futurism
Terrorists Are Using Social Media for Recruitment. Here's How We Can Stop Them.
Futurism
6.5.17, 6:34 PM EDT on futurism
A New Trial Is Using Data Servers to Heat Homeowners’ Water Supplies
Futurism
6.5.17, 1:47 PM EDT on futurism
Should We Give AIs the Same Rights as Humans?
Futurism
Updated 6.5.17, 11:46 AM EDT on futurism
Oxford Scientists Suggest That Aliens Aren't Extinct, Just Hibernating
Futurism
Updated 6.5.17, 11:06 AM EDT on futurism
An Inconvenient Truth: Man-Made Climate Change Is Real
Futurism
6.4.17, 9:00 AM EDT on futurism
This Could Mark the End of the Silicon Age
Futurism
Updated 6.3.17, 3:58 PM EDT on futurism
Blockchain Could Help Us Save the Environment. Here's How.
Futurism
6.3.17, 9:00 AM EDT on neoscope
'Leader of the Bionic Age' Suggests New Amputation Process
Futurism
6.3.17, 8:30 AM EDT on futurism
Fashion and Technology Are Merging. And It's Astounding.
Futurism
Updated 6.2.17, 4:02 PM EDT on futurism
The World's First Commercial Carbon-Capture Plant Just Went Online
Futurism
Updated 6.2.17, 12:40 PM EDT on futurism
New Research Shows Microgravity Mutates Bacteria Into Superbugs
Futurism
6.1.17, 3:54 PM EDT on neoscope
A World First CRISPR Trial Will Edit Genes Inside the Human Body
  • Previous
  • 1
  • ...
  • 12
  • 13
  • 14
  • ...
  • 18
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.